Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions

计划入组 80 人 · 首次发布于 2005 年 9 月 15 日

EndocardialVascularEndothelialGrowth Factor D(VEGF-D)Gene Therapy for the Treatment of Severe Coronary Heart Disease

计划入组 30 人 · 首次发布于 2009 年 10 月 27 日

The Effect of Anesthetic Technique on VEGF-C and PGE2

计划入组 44 人 · 首次发布于 2016 年 7 月 12 日

VEGF-C gene therapy (Herantis Pharma)

RMP-C/D-01

EG-011

C & C Oxygen Company

United States

Buchanan C Michael

United States

DENVER NEPHROLOGISTS P C

United States

Sozinibercept Shows Promise in Improving Visual Outcomes for nAMD Patients

Opthea's Sozinibercept: Phase 3 COAST Trial Completes Patient Visits, Topline Results Expected Soon

Novel Therapies for Wet AMD Target Reduced Injection Burden and Broader VEGF Inhibition